• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A call to action for improving clinical outcomes in patients with asthma.

作者信息

McIvor Andrew, Kaplan Alan

机构信息

Firestone Institute for Respiratory Health, St. Joseph's Healthcare and McMaster University, Hamilton, ON, Canada.

University of Toronto, Toronto, ON, Canada.

出版信息

NPJ Prim Care Respir Med. 2020 Dec 4;30(1):54. doi: 10.1038/s41533-020-00211-x.

DOI:10.1038/s41533-020-00211-x
PMID:33277487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7718279/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1a/7718279/881e66a6e215/41533_2020_211_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1a/7718279/df851cecc917/41533_2020_211_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1a/7718279/881e66a6e215/41533_2020_211_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1a/7718279/df851cecc917/41533_2020_211_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1a/7718279/881e66a6e215/41533_2020_211_Fig2_HTML.jpg

相似文献

1
A call to action for improving clinical outcomes in patients with asthma.改善哮喘患者临床结局的行动呼吁。
NPJ Prim Care Respir Med. 2020 Dec 4;30(1):54. doi: 10.1038/s41533-020-00211-x.
2
Which patients with asthma could benefit from using anti-leukotriene drugs: an evidence based review.
Pol Arch Med Wewn. 2008 Dec;118(12):689-90.
3
World Asthma Day. GINA 2014: a global asthma strategy for a global problem.世界哮喘日。《2014年全球哮喘防治创议》：针对全球性问题的全球哮喘防治策略。
Int J Tuberc Lung Dis. 2014 May;18(5):505-6. doi: 10.5588/ijtld.14.0246.
4
What is the evidence for different management options for difficult to treat severe asthma?
BMJ. 2017 Aug 14;358:j3403. doi: 10.1136/bmj.j3403.
5
[Drug therapy of bronchial asthma from the point of view of medicines, based on evidence].基于证据的支气管哮喘药物治疗：从药物角度看
Ter Arkh. 2003;75(3):73-7.
6
Diagnosis and treatment of asthma. What's true?
Monaldi Arch Chest Dis. 1998 Dec;53(6):700-3.
7
[Treatment of bronchial asthma in adults. Current advances].[成人支气管哮喘的治疗。当前进展]
Recenti Prog Med. 2009 Apr;100(4):171-9.
8
Clinical inquiries. Is nedocromil effective in preventing asthmatic attacks in patients with asthma?
J Fam Pract. 2004 Nov;53(11):927-8.
9
Recent asthma updates in the USA and UK.
Arch Dis Child Educ Pract Ed. 2008 Apr;93(2):66-8. doi: 10.1136/adc.2007.136879.
10
[Austrian Society of Lung Diseases and Tuberculosis: consensus on diagnosis and therapy of bronchial asthma in adults].
Wien Klin Wochenschr. 2004 May 31;116(9-10):339-45. doi: 10.1007/BF03040907.

引用本文的文献

1
Too Much SAMA, Too Many Exacerbations: A Call for Caution in Asthma.过多的短效抗胆碱能药物，过多的急性加重：哮喘治疗需谨慎呼吁
J Clin Med. 2025 Jul 16;14(14):5046. doi: 10.3390/jcm14145046.
2
Blood-Based EWAS of Asthma Polygenic Burden in The Netherlands Twin Register.荷兰双胞胎登记处中基于血液的哮喘多基因负担全基因组关联研究
Biomolecules. 2025 Feb 8;15(2):251. doi: 10.3390/biom15020251.
3
Perspectives on Treatment Decisions, Preferences, and Adherence and Long-Term Management in Asthma and COPD: A Qualitative Analysis of Patient, Caregiver, and Healthcare Provider Insights.

本文引用的文献

1
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.布地奈德福莫特罗缓解治疗与布地奈德加特布他林维持缓解治疗轻中度哮喘成人患者（PRACTICAL）：一项 52 周、开放标签、多中心、优效性、随机对照试验。
Lancet. 2019 Sep 14;394(10202):919-928. doi: 10.1016/S0140-6736(19)31948-8. Epub 2019 Aug 23.
2
GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents.《2019年全球哮喘防治创议》：哮喘管理的根本性变革：不再建议仅用短效支气管扩张剂治疗成人和青少年哮喘。
Eur Respir J. 2019 Jun 27;53(6). doi: 10.1183/13993003.01046-2019. Print 2019 Jun.
3
哮喘和慢性阻塞性肺疾病治疗决策、偏好、依从性及长期管理的观点：对患者、护理人员及医疗服务提供者见解的定性分析
Patient Prefer Adherence. 2024 Nov 14;18:2295-2306. doi: 10.2147/PPA.S467870. eCollection 2024.
4
Downregulation of protein phosphatase 2Aα in asthmatic airway smooth muscle.哮喘气道平滑肌中蛋白磷酸酶2Aα的下调
Am J Physiol Lung Cell Mol Physiol. 2024 May 1;326(5):L651-L659. doi: 10.1152/ajplung.00050.2024. Epub 2024 Mar 26.
5
Airway smooth muscle in contractility and remodeling of asthma: potential drug target mechanisms.气道平滑肌在哮喘中的收缩性和重塑：潜在的药物靶点机制。
Expert Opin Ther Targets. 2023 Jan;27(1):19-29. doi: 10.1080/14728222.2023.2177533. Epub 2023 Feb 13.
6
Proposed Strategies to Improve Adult Asthma Management in Egypt: Expert Review and Recommendations.改善埃及成人哮喘管理的建议策略：专家审查和建议。
Ann Glob Health. 2022 Nov 17;88(1):103. doi: 10.5334/aogh.3782. eCollection 2022.
7
Short-acting β-agonist prescription patterns for asthma management in the SABINA III primary care cohort.SABINA III 初级保健队列中用于哮喘管理的短效 β-激动剂处方模式。
NPJ Prim Care Respir Med. 2022 Sep 29;32(1):37. doi: 10.1038/s41533-022-00295-7.
Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.按需使用布地奈德-福莫特罗治疗轻度哮喘的对照试验。
N Engl J Med. 2019 May 23;380(21):2020-2030. doi: 10.1056/NEJMoa1901963. Epub 2019 May 19.
4
Physician-reported barriers to using evidence-based recommendations for low back pain in clinical practice: a systematic review and synthesis of qualitative studies using the Theoretical Domains Framework.医生报告在临床实践中使用基于证据的腰痛推荐的障碍：使用理论领域框架进行系统评价和定性研究的综合分析。
Implement Sci. 2019 May 7;14(1):49. doi: 10.1186/s13012-019-0884-4.
5
Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.按需吸入布地奈德-福莫特罗治疗轻度哮喘。
N Engl J Med. 2018 May 17;378(20):1865-1876. doi: 10.1056/NEJMoa1715274.
6
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.按需使用布地奈德福莫特罗与维持剂量布地奈德治疗轻度哮喘的比较。
N Engl J Med. 2018 May 17;378(20):1877-1887. doi: 10.1056/NEJMoa1715275.
7
Underdiagnosis and Overdiagnosis of Asthma.哮喘的漏诊和过度诊断。
Am J Respir Crit Care Med. 2018 Oct 15;198(8):1012-1020. doi: 10.1164/rccm.201804-0682CI.
8
Access to asthma medicines at the household level in eight counties of Kenya.肯尼亚八个县的家庭层面获得哮喘药物的情况。
Int J Tuberc Lung Dis. 2018 May 1;22(5):585-590. doi: 10.5588/ijtld.17.0664.
9
Precision medicine in airway diseases: moving to clinical practice.气道疾病精准医学：迈向临床实践。
Eur Respir J. 2017 Oct 19;50(4). doi: 10.1183/13993003.01655-2017. Print 2017 Oct.
10
The impact of inappropriate use of short acting beta agonists in asthma.哮喘中短效β受体激动剂的不恰当使用的影响。
Respir Med. 2017 Oct;131:135-140. doi: 10.1016/j.rmed.2017.08.014. Epub 2017 Aug 17.